Nottingham, United Kingdom

Barrie Walsham Bycroft


Average Co-Inventor Count = 5.1

ph-index = 5

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 1993-2003

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Barrie Walsham Bycroft

Barrie Walsham Bycroft is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of medicine through his innovative patents. With a total of six patents to his name, Bycroft has focused on developing compounds and methods that address critical health issues.

Latest Patents

Among his latest patents is a groundbreaking invention involving N-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease, or congestive heart failure. This patent provides compounds that have anti-fibrotic effects and outlines a method for treating disorders associated with pathological fibrotic states. The compounds useful in this invention include homocysteine thiolactone and selected derivatives thereof. Another significant patent focuses on a method of treating allergic disease, featuring a compound with a specific formula for use as a medicament.

Career Highlights

Throughout his career, Barrie Walsham Bycroft has worked with esteemed institutions, including the University of Nottingham. His work has contributed to advancements in medical treatments and has had a positive impact on patient care.

Collaborations

Bycroft has collaborated with notable individuals in his field, including Paul Williams and Gordon Sydney Stewart. These collaborations have likely enhanced the quality and reach of his innovative work.

Conclusion

Barrie Walsham Bycroft's contributions to the field of medicine through his patents demonstrate his commitment to innovation and improving health outcomes. His work continues to influence the medical community and offers hope for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…